Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T00:53:11.937Z Has data issue: false hasContentIssue false

2084 – Exploratory Quantum Resonance Spectrometer As a Discriminator For Psychiatric Affective Disorders

Published online by Cambridge University Press:  15 April 2020

Y. Zhang
Affiliation:
Xi’an Institute of Mental Health, Xi’an, China
F. Liu
Affiliation:
Xi’an Institute of Mental Health, Xi’an, China
J. Shi
Affiliation:
Xi’an Institute of Mental Health, Xi’an, China

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

Schizophrenia and mood disorders are chronic forms of mental illness. Quantum resonance spectrometer (QRS) test may be useful as a biological marker for the clinical diagnosis of psychiatric disorders of mental illness.

Objectives

To evaluate reliability and psychiatric clinical value of quantum resonance spectrometer (QRS) in affective disorders detection.

Methods

We studied 1014 schizophrenic patients and 248 patients with mood disorders (including 93 major depression patients). Affective disorder symptoms of same subjects obtained from QRS test and psychiatrists’ diagnoses were compared. Also 3 affective disorder symptoms of renumbered 93 major depressive patients were discriminated using QRS.

Results

Kappa values of affective disorder detection and diagnosed were more than 0.69 in all 3 symptoms of schizophrenia, and more than 0.65 in 6/7 symptoms of mood disorder. Same consistency could also be seen in Pearson R value, and ROC AUC. In the discriminated analysis, sensitivity, specificity, positive predictive value and negative predictive of hypothymia, anxiety, and irritability detected utilizing QRS are more than 0.66 compared with psychiatrists’ diagnoses.

Limitations

The study is limited by no collected psychiatric rating scale data.

Conclusion

QRS in affective disorder detection seem to have a predictable value for outcome in schizophrenia and mood disorder, would become an objective identification and diagnosis instrument, and might promote psychiatric clinical diagnosis.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.